Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer

@inproceedings{Stotz2013IncreasedNR,
  title={Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer},
  author={Michael Stotz and Armin Gerger and Florian Eisner and Joanna Szkandera and Hans Loibner and A L Ress and Peter Kornprat and W A Zoughbi and Friederike Sophia Seggewies and Carolin Lackner and Tatjana Stojakovi{\'c} and Hellmut Samonigg and Gerald Hoefler and Martin Felix Pichler},
  booktitle={British Journal of Cancer},
  year={2013}
}
Background:The neutrophil-lymphocyte ratio (NLR) has been proposed as an indicator of systemic inflammatory response. Previous findings from small-scale studies revealed conflicting results about its independent prognostic significance with regard to different clinical end points in pancreatic cancer (PC) patients. Therefore, the aim of our study was the external validation of the prognostic significance of NLR in a large cohort of PC patients.Methods:Data from 371 consecutive PC patients… CONTINUE READING